Abstract:Abstract Background Crohn’s disease (CD) and ulcerative Colitis (UC) are inflammatory bowel diseases (IBD) characterized by chronic inflammation of the digestive tract. Increasing evidence highlights the unmet need, the burden of disease, the progressive nature of the disease and subsequent intestinal damage, limited efficacy of current treatments and suboptimal disease management. The IBD-PODCAST study estimates the proportion of patients with CD and UC with suboptimal disease control (DC) in a real-world setting. Criteria for suboptimal control were largely based on STRIDE-II and modified by an expert panel (Tabel 1). We previously reported that a large proportion of patients were identified with suboptimal DC. The aim of the current analysis was to compare the patients’ and physicians’ opinion to these objective criteria of suboptimal DC in this cohort. Methods A non-interventional, cross-sectional, multi-center study was conducted. In total 2185 patients were recruited across 103 sites in 10 countries. Details on the subjective evaluation of DC from patients and physician questionnaires were compared to the objective disease criteria identifying patients with suboptimal DC. Results While 52.2% and 44.3% of patients with suboptimal DC in CD and UC, respectively, were identified based on objective criteria; only a limited proportion of patients with CD (10.9%) and UC (13.0%) reported their DC as suboptimal. Similarly, a suboptimal DC was identified by a low rate of physicians (15.7% in CD and 17.9% in UC). Impaired QoL was the main reason for suboptimal DC among CD (46.1%) and UC (51.9%) patients. Conversely, lack of biochemical lab parameter normalization was the main reason for suboptimal DC for physicians (46.6% in CD and 51.8% in UC). An aligned definition of suboptimal DC between physicians and patients was found in a quarter of patients with CD (22.3%) and in a third of cases with UC (33.0%). A concordance of suboptimal DC between patient-reported, physician-reported and objective criteria based on STRIDE-II was identified in 7.5% of CD and 12.0% of UC patients (Figure 1). Conclusion There is a high percentage of suboptimally-controlled IBD patients in this large multinational real-world cohort suggesting a large disease burden in IBD patients. There is a disconnect between objective criteria for suboptimal DC and the evaluation by the patient and the physician. Objective criteria (incl regular disease monitoring) may be essential to improve alignment in disease management and treat to target approaches. There is a strong need to improve patient-physician communication and to standardize the definition of disease control in order to improve patient management, patient-physician communication2 and the patients’ quality of life.

P732 Lack of concordance between patient-reported, physician-reported and objective criteria-based identification of suboptimal control in IBD patients: IBD PODCAST study results

P377 Proportion of IBD patients with suboptimal control in daily clinical practice – real-world evidence from the IBD Podcast study

Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study

P1145 Assessing disease control in inflammatory bowel disease (IBD) – a real world cross-sectional study in the UK

Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study

P467 Perception Gap Between Patients with Inflammatory Bowel Disease (IBD) and Physicians in China: A Cross-sectional Study

P808 Use of intestinal ultrasound influences the proportion of suboptimally controlled patients: IBD Podcast Study results

Assessing disease control in inflammatory bowel disease: a real world cross-sectional study in the UK (PODCAST-IBD)

Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial

P574 Incidence and Indicators of Suboptimal Response to Tumour Necrosis Factor Antagonist Therapy in Chinese Patients with Inflammatory Bowel Disease: Results from the EXPLORE Study

EXPLORING THE RELATIONSHIP BETWEEN PATIENT SYMPTOMS AND PROVIDER GOALS FOR MUCOSAL HEALING IN IBD: INSIGHTS FROM THE IBD QORUS SURVEY DATA

Assessment of Patient-Centered Outcomes (pros) in Inflammatory Bowel Disease (IBD): a Multicenter Survey Preceding a Cross-Disciplinary (functional) Consensus

The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis

P1077 Patients’ and Gastroenterologists’ Preferences on Outcomes and Medication Attributes for Ulcerative colitis

IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management

P654 Assessing patient-perceived burden of disease in Ulcerative Colitis: a novel scoring approach in a real-world Australasian cohort

Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey

Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: secondary analysis of a nationwide electronic survey

Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease

P529 Assessing patient-perceived burden of disease in Crohn’s disease: a novel scoring approach in a real-world Australasian cohort

P151 Assessing comprehensive remission for Ulcerative Colitis in clinical practice: International consensus recommendations